UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by J.Safra Asset Management Corp

J.Safra Asset Management Corp boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 40.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,889 shares of the healthcare conglomerate’s stock after purchasing an additional 541 shares during the quarter. J.Safra Asset Management Corp’s holdings in UnitedHealth Group were worth $959,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in UNH. Cookson Peirce & Co. Inc. grew its position in shares of UnitedHealth Group by 4.4% during the fourth quarter. Cookson Peirce & Co. Inc. now owns 2,375 shares of the healthcare conglomerate’s stock worth $1,201,000 after acquiring an additional 100 shares during the last quarter. Snider Financial Group grew its position in UnitedHealth Group by 16.6% in the 4th quarter. Snider Financial Group now owns 6,580 shares of the healthcare conglomerate’s stock worth $3,328,000 after purchasing an additional 938 shares during the last quarter. Triad Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $1,198,000. Carrera Capital Advisors increased its position in UnitedHealth Group by 9.3% in the 4th quarter. Carrera Capital Advisors now owns 553 shares of the healthcare conglomerate’s stock valued at $280,000 after acquiring an additional 47 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of UnitedHealth Group by 3.8% during the fourth quarter. Victory Capital Management Inc. now owns 627,739 shares of the healthcare conglomerate’s stock valued at $317,548,000 after purchasing an additional 22,788 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.6 %

UnitedHealth Group stock opened at $474.58 on Wednesday. The firm’s 50 day moving average price is $515.18 and its two-hundred day moving average price is $555.37. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm has a market cap of $436.74 billion, a PE ratio of 30.62, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.83 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.